The Consortium for Clinical Research and Innovation Singapore (CRIS) is a wholly owned subsidiary of MOH Holdings established in 2020 to strengthen synergies and promote strategies for national-level clinical research and translation programs under the stewardship of the Singapore Ministry of Health...See more
Headquarters:
Singapore
Company Type:
SME
Company size:
51-200 Employees
Year Founded:
2020 (6 years)
Address:
23 ROCHESTER PARK; #06-01; SINGAPORE, 139234, SG
Employees by Department
- IT / Product (12)
- Operations (2)
- Sales (1)
- The Rest (32)
- Total (47)
Key Decision Makers
Insight
The company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between January - March
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has CONSORTIUM FOR CLINICAL RESEARCH AND INNOVATION, SINGAPORE (CRIS) been operating for?
- What is the funding status of CONSORTIUM FOR CLINICAL RESEARCH AND INNOVATION, SINGAPORE (CRIS)?
- Where is CONSORTIUM FOR CLINICAL RESEARCH AND INNOVATION, SINGAPORE (CRIS)'s headquarter?
- What CONSORTIUM FOR CLINICAL RESEARCH AND INNOVATION, SINGAPORE (CRIS)'s spending power?
- Does CONSORTIUM FOR CLINICAL RESEARCH AND INNOVATION, SINGAPORE (CRIS) have a presence in the domain it operates in?
